Drug Approval | April 17, 2026
Morepen Laboratories secures fourth consecutive USFDA ‘NIL 483’ inspection
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
The company reported net revenue of SEK 13.5 million for the full year 2025
The national platform brought together healthcare professionals, patient advocates, and stakeholders
This development signals a cleanup of Anlon’s borrowing profile and closure of legacy debt facilities
The online platform is designed to go beyond clinical treatment, offering practical tools, lived-experience insights, and peer-informed support intended to reduce isolation and improve day-to-day coping
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
The grant backed by Novartis to strengthen academia-industry collaboration across all seven NIPERs
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Subscribe To Our Newsletter & Stay Updated
